The AICDA gene helps certain immune cells refine antibodies, so your body can build a stronger defense after infections or vaccines. If it does not work properly, people may develop a rare inherited immune condition with repeated infections because the body struggles to make the right mix of antibodies. This gene plays an important role in helping B cells, a type of white blood cell, switch from early antibodies to more effective ones. AICDA is mostly known in medical genetics rather than in popular culture.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain activities happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medicines. For a deeper look at this topic, visit the LearnHub.
Overview
AICDAGene function
What if the gene works
The AICDA gene helps B cells improve antibodies and switch antibody classes. This supports a more targeted immune response and longer lasting protection after infections or vaccines.
Risk
What if the gene does not work
More disruptive variants in the AICDA gene can cause autosomal recessive hyper-IgM syndrome type 2, with frequent infections because the body struggles to switch antibody types. Milder variants may cause later onset or a less pronounced immune problem.
Treatment
What does that mean for your treatment
With pathogenic variants in the AICDA gene, treatment usually centers on regular immunoglobulin replacement and prompt treatment or prevention of bacterial infections. Unlike some other hyper-IgM causes, stem cell transplant is not routinely used for AICDA deficiency because T cell immunity is usually preserved.
Conditions associated with AICDA
Gene function
What if the gene works
When your body meets a new germ, some immune cells need to fine tune their antibodies so they recognize that target better. The AICDA gene helps make this possible in B cells, the white blood cells that produce antibodies. It also helps these cells switch antibody type so the response fits different parts of the body.
In activated B cells, the AICDA gene helps create tiny planned DNA edits in the part of an antibody that grabs onto germs. This lets the immune system test new antibody versions and keep ones that attach more tightly.
The AICDA gene helps B cells switch from making one antibody type to another while keeping the same target. This is part of how the AICDA gene helps the immune system make the right antibody for blood, airways, the gut, and other tissues.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change how a gene works to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AICDA gene can change the AID protein’s shape, stability, or activity, so B cells are less able to edit antibody genes. This explains how AICDA gene variants affect the AID protein and, in turn, antibody class switching, the process that changes one antibody type into another. Milder variants may leave some activity, while more severe variants can remove it almost completely and are often linked to earlier or more pronounced immune findings.
How variants are linked to conditions
Pathogenic variants in both copies of the AICDA gene cause hyper-IgM syndrome type 2, a rare inherited immune condition. People with AICDA gene variants linked to hyper-IgM syndrome type 2 often have low IgG and IgA levels with normal or high IgM, and may have repeated ear, sinus, lung, or gut infections. Some also develop swollen lymph nodes, enlarged tonsils, or autoimmune problems.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are common across the general population. Most have no direct impact on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the AICDA gene. For people with disease-causing changes in both copies of AICDA, the main issue is the inherited immune condition itself, and day-to-day care focuses more on preventing infections and watching for complications than on changing risk through lifestyle.
Inheritance of AICDA variants
Variants in the AICDA gene are inherited in an autosomal recessive pattern. This means a child usually inherits one nonworking copy from each parent. Parents who each carry one AICDA gene variant are typically unaffected, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In families affected by AICDA inheritance, this pattern is the usual way the condition is passed on.
What does my AICDA result mean for my family?
AICDA results can have different family implications depending on the specific change. Some AICDA-related immune conditions run in families in a recessive pattern, which can mean brothers and sisters may also be affected or parents may be healthy carriers. Other AICDA changes have been linked to a dominant pattern, where close relatives may also carry the same change. Because of this, the meaning for family members depends on the exact AICDA result.
Genetic information
Genetic testing
How you find out about variants
To find variants in the AICDA gene, doctors use genetic testing for AICDA variants on a blood sample or saliva sample. A lab reads the gene’s DNA code and looks for changes linked to inherited immune conditions. Results may show a disease causing variant, a benign variant, or an unclear finding.
When should I consider getting a genetic test?
Consider testing for changes in the AICDA gene if there are repeated infections and blood tests show a pattern of very low infection-fighting antibodies with one type staying normal or high, often starting in childhood. It can also help when this immune condition runs in the family or a close relative has a known AICDA change.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the specific type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target. Because of this, the same medication may work better for some people, seem less effective for others, or cause more side effects in some than in others. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences can shape a person’s response to medication. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how the body processes a drug or how strong its effects are. This understanding can support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the AICDA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or predicting medication response, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
Across cultures and time periods, inherited patterns were noted, but the molecular story behind antibody related immune conditions became much clearer in the early 2000s. In 2000, researchers identified the AICDA gene as the cause of a rare inherited condition marked by very high IgM antibody levels and problems making other antibody types. This discovery helped connect clinical observations from immunology clinics with a specific genetic cause. From these first observations, research expanded steadily. Scientists soon recognized that the AICDA gene was central to a major shift in understanding how the immune system changes its antibody response over time. That work gave AICDA a lasting place in modern immunology and medical genetics.